NASDAQ:BIS ProShares UltraShort Nasdaq Biotechnology Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $31.47 +0.29 (+0.93 %) (As of 09/18/2020 12:37 PM ET) Add Share Today's Range$30.93Now: $31.47▼$31.4750-Day Range$30.68MA: $33.04▼$36.0352-Week Range$27.84Now: $31.47▼$85.80Volume529 shsAverage Volume61,528 shsMarket Capitalization$14.04 millionP/E RatioN/ADividend Yield0.48%BetaN/A ProfileChartDividendInstitutional OwnershipHeadlinesOptions ChainShort InterestSocial Media ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Read More Geographic Exposure of BISCurrency Exposure of BIS Basic Details Issuer ProShares Fund NameProShares UltraShort Nasdaq Biotechnology Tax ClassificationRegulated Investment Company SymbolNASDAQ:BIS Inception Date4/6/2010 Fund ManagerMichael Neches, Tarak Dave Webwww.proshares.com Phone+1-240-4976400 Fund Focus Asset ClassEquity BenchmarkNasdaq Biotech Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$19.04 million Average Daily Volume$100,288.40 Discount/Premium0.02% ETF Expenses Management Fee0.75% Other Expenses0.36% Total Expenses1.11% Fee Waiver-0.16% Net Expenses0.95%Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. Trustee Lead Market MakerVirtu Financial $31.47 +0.29 (+0.93 %) (As of 09/18/2020 12:37 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive BIS News and Ratings via Email Sign-up to receive the latest news and ratings for BIS and its competitors with MarketBeat's FREE daily newsletter. ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Frequently Asked Questions How has ProShares UltraShort Nasdaq Biotechnology's stock price been impacted by COVID-19 (Coronavirus)? ProShares UltraShort Nasdaq Biotechnology's stock was trading at $64.52 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BIS stock has decreased by 51.7% and is now trading at $31.17. View which stocks have been most impacted by COVID-19. How often does ProShares UltraShort Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares UltraShort Nasdaq Biotechnology? ProShares UltraShort Nasdaq Biotechnology announced a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be given a dividend of $0.1057 per share on Wednesday, April 1st. This represents a $0.42 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend is Wednesday, March 25th. This is an increase from ProShares UltraShort Nasdaq Biotechnology's previous quarterly dividend of $0.04. View ProShares UltraShort Nasdaq Biotechnology's dividend history. When did ProShares UltraShort Nasdaq Biotechnology's stock split? How did ProShares UltraShort Nasdaq Biotechnology's stock split work? ProShares UltraShort Nasdaq Biotechnology shares reverse split on Tuesday, August 18th 2020. The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 17th 2020. An investor that had 100 shares of ProShares UltraShort Nasdaq Biotechnology stock prior to the reverse split would have 25 shares after the split. Are investors shorting ProShares UltraShort Nasdaq Biotechnology? ProShares UltraShort Nasdaq Biotechnology saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 16,300 shares, a drop of 81.2% from the August 15th total of 86,800 shares. Based on an average trading volume of 102,400 shares, the days-to-cover ratio is currently 0.2 days. View ProShares UltraShort Nasdaq Biotechnology's Short Interest. What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraShort Nasdaq Biotechnology investors own include Inovio Pharmaceuticals (INO), Sanofi (SNY), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX), Micron Technology (MU), (MRNA), Cidara Therapeutics (CDTX) and Vertex Pharmaceuticals (VRTX). What is ProShares UltraShort Nasdaq Biotechnology's stock symbol? ProShares UltraShort Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIS." Who are ProShares UltraShort Nasdaq Biotechnology's major shareholders? ProShares UltraShort Nasdaq Biotechnology's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Wealthsource Partners LLC (4.50%), Lindbrook Capital LLC (0.57%) and Simplex Trading LLC (0.59%). View institutional ownership trends for ProShares UltraShort Nasdaq Biotechnology. Which major investors are buying ProShares UltraShort Nasdaq Biotechnology stock? BIS stock was purchased by a variety of institutional investors in the last quarter, including Wealthsource Partners LLC, Lindbrook Capital LLC, and Simplex Trading LLC. View insider buying and selling activity for ProShares UltraShort Nasdaq Biotechnology. How do I buy shares of ProShares UltraShort Nasdaq Biotechnology? Shares of BIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is ProShares UltraShort Nasdaq Biotechnology's stock price today? One share of BIS stock can currently be purchased for approximately $31.17. How big of a company is ProShares UltraShort Nasdaq Biotechnology? ProShares UltraShort Nasdaq Biotechnology has a market capitalization of $13.90 million. What is ProShares UltraShort Nasdaq Biotechnology's official website? The official website for ProShares UltraShort Nasdaq Biotechnology is www.proshares.com. How can I contact ProShares UltraShort Nasdaq Biotechnology? ProShares UltraShort Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, Bethesda, MD 20814, United States. The company can be reached via phone at +1-240-4976400. This page was last updated on 9/18/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
